Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update
01 sept. 2023 17h57 HE
|
Turnstone Biologics Corp.
Successfully closed upsized IPO, raising $88 million in gross proceeds to continue advancing pipeline of Selected TIL Therapy programsCash position expected to fund operations into second quarter of...
Global CAR T-Cell Therapy Market Size on a Meteoric Rise: Envisioning $2406.39 Million by 2030 with a Striking CAGR of 26.20%
23 août 2023 04h51 HE
|
Zion Market Research
New York, NY, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “CAR T-Cell Therapy Market By Drug Type (Axicabtagene Ciloleucel, Brexucabtagene...
Gemcitabine HCL Market to Achieve CAGR of 7.4%, Exceeding US$ 1.3 Bn by 2031
26 juil. 2023 09h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, July 26, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The gemcitabine HCL market was valued at US$ 635.1 Mn in 2021 and is projected to exceed...
Elevar Therapeutics Announces Publication of Phase 3 CARES 310 Study Results in The Lancet
24 juil. 2023 21h39 HE
|
Elevar Therapeutics
FORT LEE, N.J., July 24, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating...
Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering
21 juil. 2023 02h15 HE
|
Turnstone Biologics Corp.
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing new medicines to treat and cure...
Elevar Therapeutics Announces FDA Acceptance for Filing of New Drug Application for Rivoceranib in Combination with Camrelizumab as a First-line Treatment for Unresectable Hepatocellular Carcinoma
17 juil. 2023 09h00 HE
|
Elevar Therapeutics
FORT LEE, N.J., July 17, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd., and a fully integrated biopharmaceutical company dedicated to elevating...
"The Future of Medical Procedures: Understanding the Radiofrequency Ablation Devices Market (+CAGR of 11.6%) ", Says Market.us
05 juil. 2023 08h59 HE
|
Market.Us
New York, July 05, 2023 (GLOBE NEWSWIRE) -- The Radiofrequency Ablation Devices Market in terms of revenue was estimated to be worth USD 4.3 Bn in 2022 and is poised to reach USD 12.5 Bn by 2032,...
Antibody Drug Conjugates Market to surpass USD 26.5 billion by 2032, says Global Market Insights Inc.
20 juin 2023 20h00 HE
|
Global Market Insights Inc.
Selbyville, Delaware, June 20, 2023 (GLOBE NEWSWIRE) -- Antibody Drug Conjugates Market size will cross USD 26.5 billion by 2032. Growing advancements in antibody engineering and conjugation...
Thermosome Announces Participation in IMAGIO Consortium to Improve Cancer Treatment
20 juin 2023 04h00 HE
|
AKAMPION
IMAGIO consortium of clinical partners coordinated by Philips receives EUR 24 million grant from the Innovative Health Initiative (IHI) and additional funding from industry partners to support the...
Hyperthermia Cancer Treatment Market to Grow 5.9% CAGR, Worth US$ 266 Million by 2030 | TMR Study
02 juin 2023 08h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, June 02, 2023 (GLOBE NEWSWIRE) -- The global hyperthermia cancer treatment market stood at US$ 147.6 million in 2019 and the global market is projected to reach...